ChiCTR2400090693 版本V1.0 版本创建时间2024/10/11 17:47:35 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2400090693 

最近更新日期:

Date of Last Refreshed on:

2024-10-11 17:47:16 

注册时间:

Date of Registration:

2024-10-11 00:00:00 

注册号状态:

补注册

Registration Status:

Retrospective registration

注册题目:

自我表露干预在孤独症谱系障碍儿童父母中的应用研究

Public title:

Application of Self-Disclosure Intervention in Parents of Children with Autism Spectrum Disorders

注册题目简写:

English Acronym:

研究课题的正式科学名称:

自我表露干预在孤独症谱系障碍儿童父母中的应用研究

Scientific title:

Application of Self-Disclosure Intervention in Parents of Children with Autism Spectrum Disorders

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

黄伊 

研究负责人:

黄伊 

Applicant:

Huang Yi 

Study leader:

Huang Yi 

申请注册联系人电话:

Applicant telephone:

+86 158 0260 9130

研究负责人电话:

Study leader's
telephone:

+86 158 0260 9130

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

2214086551@qq.com

研究负责人电子邮件:

Study leader's E-mail:

2214086551@qq.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

湖南省长沙市岳麓区桐梓坡路371号湖南师范大学医学院护理系

研究负责人通讯地址:

湖南省长沙市岳麓区桐梓坡路371号湖南师范大学医学院护理系

Applicant address:

Nursing Department, Medical College, Hunan Normal University, No. 371, Tongzipo Rd, Yuelu District, 410013 Changsha, China

Study leader's address:

Nursing Department, Medical College, Hunan Normal University, No. 371, Tongzipo Rd, Yuelu District, 410013 Changsha, China

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

湖南师范大学

Applicant's institution:

Hunan Normal University

研究负责人所在单位:

湖南师范大学

Affiliation of the Leader:

Hunan Normal University

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

伦审科2024第(053)号

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

湖南师范大学伦理委员会

Name of the ethic committee:

Ethics Committee of Hunan Normal University

伦理委员会批准日期:

Date of approved by ethic committee:

2024-03-04 00:00:00

伦理委员会联系人:

何祖平

Contact Name of the ethic committee:

He Zuping

伦理委员会联系地址:

湖南省长沙市岳麓区桐梓坡路371号湖南师范大学医学院

Contact Address of the ethic committee:

Nursing Department, Medical College, Hunan Normal University, No. 371, Tongzipo Rd, Yuelu District, 410013 Changsha, China

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 152 4367 3137

伦理委员会联系人邮箱:

Contact email of the ethic committee:

1270136903@qq.com

研究实施负责(组长)单位:

湖南师范大学

Primary sponsor:

Hunan Normal University

研究实施负责(组长)单位地址:

湖南省长沙市岳麓区桐梓坡路371号湖南师范大学医学院

Primary sponsor's address:

Nursing Department, Medical College, Hunan Normal University, No. 371, Tongzipo Rd, Yuelu District, 410013 Changsha, China

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

湖南省

市(区县):

Country:

China

Province:

Hunan province

City:

单位(医院):

湖南师范大学

具体地址:

湖南省长沙市岳麓区桐梓坡路371号湖南师范大学医学院

Institution
hospital:

Hunan Normal University

Address:

Nursing Department, Medical College, Hunan Normal University, No. 371, Tongzipo Rd, Yuelu District, 410013 Changsha, China

经费或物资来源:

湖南师范大学医学院开放基金项目

Source(s) of funding:

Open Fund Project of Hunan Normal University Medical College

研究疾病:

孤独症谱系障碍  

Target disease:

autism spectrum disorder

研究疾病代码:

Target disease code:

研究类型:

干预性研究

Study type:

Interventional study

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

随机平行对照 

Study design:

Parallel 

研究目的:

以应激理论为指导,探讨自我表露干预在ASD儿童父母中的应用效果;通过凯斯勒心理困扰量表、亲职压力简表、照顾者疾病获益感中文版量表、简易应对方式问卷、连带内化污名量表对干预效果进行评价。  

Objectives of Study:

Guided by the theory of stress, this study explores the application effectiveness of self-disclosure intervention among parents of children with Autism Spectrum Disorder (ASD). The intervention effects are evaluated using the Kesler Psychological Distress Scale, Parenting Stress Index Short Form, Chinese version of Benefit Finding Scale, Simplified Copying Style Questionnaire, and Affiliate Stigma Scale.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

纳入标准:①年龄≤14岁的ASD儿童的父亲/母亲;②ASD儿童符合美国精神障碍诊断与统计手册第5版 (DSM-V)中ASD的诊断标准,并具有医院开具的诊断报告;③能够理解和完成各项干预内容,并签署知情同意书。

Inclusion criteria

1. Fathers/mothers of ASD children aged ≤14 years old; 2. ASD children who meet the diagnostic criteria for ASD in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5), and have a diagnostic report issued by a hospital; 3. Ability to understand and complete the intervention content and sign an informed consent form.

排除标准:

排除标准:①患有严重精神疾病或存在沟通交流障碍;②近2年有其他重大心理创伤事件经历。

Exclusion criteria:

1. Presence of severe mental illness or communication disorders; 2. Experience of other major psychological trauma events in the past 2 years.

研究实施时间:

Study execute time:

From 2024-02-26 00:00:00 To 2024-10-27 00:00:00  

征募观察对象时间:

Recruiting time:

From 2024-03-20 00:00:00 To 2024-09-10 00:00:00

干预措施:

Interventions:

组别:

对照组

样本量:

36

Group:

Control Group

Sample size:

干预措施:

常规健康教育

干预措施代码:

Intervention:

Routine health education

Intervention code:

组别:

干预组

样本量:

36

Group:

Intervention Group

Sample size:

干预措施:

自我表露干预+常规健康教育

干预措施代码:

Intervention:

Self-Disclosure Intervention + Routine health education

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

湖南省 

市(区县):

 

Country:

China

Province:

Hunan province

City:

单位(医院):

湖南光琇医院 

单位级别:

二级 

Institution
hospital:

Hunan Guangxiu Hospital

Level of the institution:

Secondary

测量指标:

Outcomes:

指标中文名:

心理困扰

指标类型:

主要指标

Outcome:

Psychological Distress

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

亲职压力

指标类型:

主要指标

Outcome:

Parenting Stress

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

照顾者疾病获益感

指标类型:

次要指标

Outcome:

Benefit Finding

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

应对方式

指标类型:

次要指标

Outcome:

Copying Style

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

连带内化污名

指标类型:

主要指标

Outcome:

Affiliate Stigma

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

none

Tissue:

人体标本去向

其它  

说明

Fate of sample:

0thers  

Note:

征募研究对象情况:

Recruiting status:

正在进行

Recruiting

年龄范围:

Participant age:

最小 Min age 18 years
最大 Max age 50 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

根据纳入的顺序对ASD儿童父母依次进行编号,按照随机数字表法,将随机数字表生成的随机数字录入编号,每个编号对应1个随机数字,将随机数字从小到大排序,前36个随机数字对应的编号为干预组,后36个随机数字对应的编号为对照组。

Randomization Procedure (please state who generates the random number sequence and by what method):

Parents who met the inclusion and exclusion criteria were sequentially numbered according to their inclusion order. Using the random number table method, random numbers generated by the random number table were assigned to the corresponding numbers, and then these numbers were sorted from smallest to largest. The first 36 numbers corresponded to the intervention group, while the following 36 numbers corresponded to the control group.

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

不公开/Private

盲法:

Blinding:

None

是否共享原始数据:

IPD sharing

是Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

研究结果发表后向研究者联系索取

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

After the research results are published, please contact the researchers to request a copy.

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

使用问卷调查收集数据,使用SPSS软件录入和分析数据

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Collect data using questionnaires, enter and analyze data using SPSS software.

数据与安全监察委员会:

Data and Safety Monitoring Committee:

暂未确定/Not yet

注册人:

Name of Registration:

 2024-10-11 17:47:16